
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Hepatic encephalopathy(HE)is a severe complication of cirrhosis that is related to the effect of excess ammonia.The present study was constructed to investigate the potent role of L-carnitine, α-lipoic acid either individually or in combination in management of hepatic encephalopathy in adult male rats. The aim of this study was extended to elucidate the most effective therapy against experimental hepatic encephalopathy. The present results revealed that the treatment with lactulose, L-carnitine, α-lipoic acid or a combined dose of L-carnitine and α-lipoic acid resulted in pronounced improvement in the liver functions accompanied with significant modulation in hepatic and brain oxidant/antioxidant homeostasis in addition to marked suppression in the inflammatory mediators. Also, the selected treatments could restore the structural organization of liver and brain. In conclusion, the present study provided clear evidences for the effectiveness of L-carnitine, α-lipoic acid or their combination in the regression of hepatic encephalopathy induced chemically in rats. This effect was achieved through the antioxidant, anti-inflammatory and antifibrotic potential of these nutraceuticals.
This study investigates the therapeutic potential of specific nutraceuticals in managing hepatic encephalopathy (HE) in a rat model. The research focuses on L-carnitine and α-lipoic acid, examining their individual and combined effects on liver function, oxidant/antioxidant balance, and inflammatory mediators in rats with chemically induced HE. The authors aimed to determine the most effective therapeutic strategy among lactulose, L-carnitine, α-lipoic acid, and their combination, assessing their impact on liver and brain structure and homeostasis.
The study provides experimental evidence for the efficacy of L-carnitine and α-lipoic acid, alone or in combination, in mitigating chemically induced hepatic encephalopathy in rats. The findings suggest these nutraceuticals can improve liver function, restore oxidant/antioxidant balance, suppress inflammation, and aid in the structural recovery of liver and brain tissues. The research highlights the potential of these compounds as therapeutic agents through their antioxidant, anti-inflammatory, and antifibrotic properties. This work contributes to the understanding of novel therapeutic approaches for hepatic encephalopathy.
Page Count:
292
Publication Date:
2015-01-01
Publisher:
Lap Lambert Academic Publishing GmbH KG
ISBN-10:
3659688029
ISBN-13:
9783659688027
No comments yet. Be the first to share your thoughts!